Penile Squamous Cell Carcinoma: Penis-Preserving Treatment With Mohs Micrographic Surgery

Dermatol Surg. 2016 Aug;42(8):936-44. doi: 10.1097/DSS.0000000000000795.

Abstract

Background: There have been few published case series of penile squamous cell carcinoma (SCC) removed with Mohs micrographic surgery (MMS). Of these case series, the published cure rates are between 68% and 74%.

Objective: To report 30 years of experience removing penile SCCs with MMS.

Methods and materials: Retrospective record review of 42 patients with 44 penile SCCs.

Results: There was one recurrence of the 19 primary SCCs in situ, resulting in a cure rate of 94.7%. There were no recurrences among the 10 primary invasive SCC. Of the 6 recurrent invasive SCCs, 2 recurred, resulting in an initial cure rate of 66.7%. These 2 recurrences were re-treated with MMS with no evidence of recurrence at 5 years. There were 4 patients with SCC in situ of the glans with extension down the urethra. While all 4 patients required urethral dilation postoperatively secondary to urethral stricture, none of these tumors recurred and normal function was restored in each case.

Conclusion: In conclusion, MMS may be preferred for patients with penile carcinoma by providing a high cure rate and tissue conservative alternative to partial or total penectomy and does not need to be limited to low-grade, small, superficial tumors.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma in Situ / surgery*
  • Carcinoma, Squamous Cell / surgery*
  • Humans
  • Male
  • Middle Aged
  • Mohs Surgery* / adverse effects
  • Mohs Surgery* / methods
  • Neoplasm Recurrence, Local / surgery*
  • Organ Sparing Treatments*
  • Penile Neoplasms / surgery*
  • Postoperative Complications / etiology
  • Postoperative Complications / therapy
  • Reoperation
  • Retrospective Studies
  • Skin Neoplasms / surgery*
  • Urethral Stricture / etiology
  • Urethral Stricture / therapy